Maternal obesity associates with multiple adverse reproductive outcomes, negatively affecting the 2 health and survival of both the mother and the fetus. The contributory effects of obesity on adipose-3 derived immune changes have been well established, however the mechanisms that link obesity to 4 pregnancy complications remain unclear. Proper development of the placenta and establishment of 5 utero-placental vasculature is essential in early pregnancy to allow for optimal fetal growth and 6 survival. Uterine immune cells, particularly uterine natural killer (uNK) cells, play fundamental roles in 7 promoting these events. Using an obesogenic high-fat/high-sucrose (HFD) mouse model of maternal 8 obesity, uNK cells and placenta/uterine vascular remodeling were examined at gestational days (Gd) 9 10.5 and 14.5 of pregnancy. While mice fed a HFD 13 weeks prior to pregnancy significantly gained 10 more weight than control mice fed a low-fat/no-sucrose diet (LFD), fetal survival was not different in 11 either diet. At Gd 10.5, HFD had no effect on total uNK proportions, nor did it affect proportions of 12 distinct CD122+/CD49a tissue resident or CD122+/DX5+ conventional uNKs. However, HFD resulted 13 in increased proportions of NCR1+ uNK and overall heightened uNK activity. Moreover, HFD resulted 14 in impairments in uterine vascular remodeling at Gd10.5. By Gd14.5, uterine artery defects were no 15 longer observed and placental structure was comparable between HFD and LFD mice. Gene analysis of 16 IFNγ, TNFα and VEGFA in Gd10.5 uNK indicated that, while not significant, a HFD leads to subtle 17 alterations in uNK cytokine gene expression. These findings show that HFD in mice results in changes 18 in uNK biology and temporary uterine artery remodeling impairments. Further, this work establishes 19 insight into the cellular changes occurring in early pregnancy as a result of HFD exposure. 20 21
CIA-CAAA) (to AGB). 4
INTRODUCTION 1
Obesity affects more than half a billion adults worldwide and has become a global epidemic 1 . 2 Consistent with trends in general population, rates of obesity among women of childbearing age are 3 increasing rapidly [2] [3] [4] . Pre-pregnancy obesity is recognized as a high-risk state because of its association 4 with multiple adverse obstetric and perinatal outcomes including miscarriage, preeclampsia, preterm 5 birth and intrauterine fetal demise 5 . Providing the interface between the mother and developing baby, 6 the placenta plays a key role in mediating the effect of the adverse maternal environment to the fetus 6, 7 . 7
Studies in rodents have established the effect of maternal obesity on placental dysfunction reflected in 8 part by vascular impairments within the maternal-fetal interface [8] [9] [10] . However, the molecular 9 mechanisms that link detrimental pregnancy outcomes to pre-gravid obesity are poorly understood. 10
Optimal placental function and overall pregnancy success is largely dependent upon the proper 11 establishment of fetal and maternal circulations within the fetal-maternal interface; these processes are 12 controlled by tightly regulated angiogenic and vascular remodeling programs 11, 12 . Early stages of blood 13 vessel growth, branching, pruning, and remodeling are controlled by diverse leukocyte populations that 14 localize within the decidual microenvironment of the uterus 13, 14 . Uterine natural killer (uNK) cells 15 constitute the most abundant immune cell population within both human and murine uterus in early 16 pregnancy [15] [16] [17] , and genetic studies in mice show that these cell types are major contributors to uterine 17 vascular transformations [18] [19] [20] . 18
Despite a number of physiological and anatomical differences that exist between human and 19 murine pregnancy, uNK cell function and regulation of uNK-governed events are comparable between 20 these species. uNK cells in human pregnancy facilitate the initial stages of arterial vascular 21 transformation and control extravillous trophoblast invasion 13 . While distinct uNK subtypes in human 22 decidua are less well-defined, at least two functionally distinct populations of uNK cells in mice have 23 been classified, and are characterized by their reactivity to Dolichos biflorus agglutin (DBA) and cell-1 surface expression of CD49a and DX5 21 . DBA + CD49a + DX5 +/-define a tissue-resident uNK population 2 and predominantly mediate angiogenic growth factor production (VEGFA, PGF) 21, 22 , whereas DBA -3
CD49a
-DX5 + identify a conventional uNK population that preferentially produces IFNγ and play roles 4 in uterine vasculature remodeling 18, 21, 22 . In summary, uNK cell-directed processes are critical to 5 successful pregnancy. 6
Obesity is characterized by adipose tissue expansion and infiltration of immune cells, including 7 macrophages, T lymphocytes, B cells, mast cells, and neutrophils [23] [24] [25] . Along with increase in numbers 8 of immune cells, obesity/adipose-related environment alters leukocyte activation within adipose tissue, 9
potentiating the secretion of pro-inflammatory cytokines that have both local and distal effects 26 . For 10 example, obesity associates with aberrant activation of liver 27 and pancreatic 28 macrophages, and 11 alterations in the macrophage immune cell function is thought to contribute to obesity-related 12 metabolic diseases 29 . This indicates that obesity-related immune alterations within reproductive tissues 13 like the uterus and placenta may also be impacted. Since uNK cell differentiation, maturation, and 14 activity are highly influenced by soluble factors like cytokine and hormones, as well as through direct 15 cellular interactions 30, 31 , the uterine microenvironment in obesity may play an important role in shaping 16 uNK-related processes that affect pregnancy. 17
In this study, we aimed to investigate the impact of high-fat/high-sucrose obesogenic diet 18 (HFD) on uNK cell function and placental development in early-mid pregnancy in mice. We 19 demonstrate that uNK cells from HFD mice show changes in natural killer cell receptor composition 20 and activation status. Importantly, a HFD promoted impaired spiral artery remodeling within an early-21 mid pregnancy and potentiated the differential expression of uNK-derived cytokines at mid-gestation. 22
Together, our work provides novel insight into HFD-induced changes in uNK cell function and uterine 1 vascular transformations in early-mid pregnancy. Maternal obesity drives inflammation in early pregnancy with no effect on fetal viability 2
To investigate the effects of maternal obesity on uterine natural killer cell biology and placental 3 development, we established a murine model of diet-induced obesity, where female C57BL/6J mice 4 were fed a high-fat/high-sucrose diet (HFD) or low-fat/no-sucrose diet (LFD) over the period of 13 5 weeks before mating and during pregnancy ( Figure 1A ). As expected, exposure to HFD resulted in a 6 significant body weight gain over the course of 13 weeks ( Figure 1B ). Similar to this trend, HFD-fed 7 mice continued gaining weight at a progressive rate throughout gestation ( Figure 1C ). HFD was also 8 associated with the induction of pro-inflammatory state in early-mid pregnancy (Gd10.5), reflected by 9 the heightened maternal serum concentrations of TNFα, an important mediator of systemic 10 inflammation 32 ( Figure 1D ). Despite having profound effects on maternal parameters, HFD did not 11 affect overall fetal survival, where numbers of live conceptuses and a rate of fetal resorption remained 12 unchanged between HFD-and LFD-fed mice at Gd14.5 ( Figure 1E, F) . This finding is consistent with 13 our previous work showing that while maternal HFD leads to changes in maternal physiology and 14 metabolic profile, including a significant weight gain before and during pregnancy, hyperglycemia and 15 glucose intolerance, detrimental consequences on fetal parameters are not observed 33 34 , their numbers were not affected by diet (Figure 2A) . 3
Following this, we went on to examining the proportions of total leukocytes (CD45 + ) and uNKs (CD3 -4 CD122 + ), as well as specific tr-uNK and c-uNK sub-populations at Gd10.5 by flow cytometry ( Figure  5 2B). We chose Gd10.5 to be an appropriate time point for uNK-related assessments, since these uNK 6 cells peak in numbers at mid-gestation 21 . HFD had a little effect on total immune cell and uNK cell 7 proportions ( Figure 2C ). Confirming our qualitative observations, HFD did not exert any measurable 8 effect on the tr-uNK and c-uNK in-utero balance ( Figure 2D ). 9
Natural cytotoxicity receptor 1 (NCR1) is a known activating receptor expressed on uNKs that 10 is essential for uNK cell maturation and function, including blood vessel remodeling 35, 36 . Thus, to 11 further elucidate effects of maternal HFD on uNK cell biology, we assessed uNK NCR1 expression. 12 Interestingly, we found that HFD drives an increase in the proportion of CD122 + NCR1 + uNK; NCR1 13 expression levels [measured by median fluorescent intensity (MFI)] are not affected ( Figure 2E ). These 14 findings suggest that maternal obesity manifests in subtle changes in uNK cell composition in early-15 mid pregnancy, promoting acquisition of NCR1. 16 HFD promotes a shift in uNKs towards an activated phenotype at Gd10. 5 by DBA-labeling fluorescence microscopy. Differences in DBA + uNK cell diameters between diet 1 groups were not observed ( Figure 3A ). Following this, we proceeded to investigate the expression of 2 CD69, an early NK cell activation marker 37 in CD122 + and CD122 + NCR1 + uNK cells by flow 3 cytometry ( Figure 2B ). Notably, expression levels (MFI) of CD69, but not CD69 + cell proportions, 4
were significantly elevated in CD122 + and CD122 + NCR1 + uNK cell populations as a result of HFD 5 (Figure 3C, D) . These observations suggest that while not directly affecting maturation of uNK cells, 6
HFD promotes a shift towards the activation of these cells in early-mid pregnancy. 7 8 HFD impairs spiral artery remodeling in mid pregnancy 9
Early pregnancy spiral artery (SA) remodeling is a process controlled and regulated by uNKs 38 . 10 NCR1 is known to play a role in uNK-mediated spiral artery remodeling 36 . Thus, we next set out to 11 address whether HFD-induced changes observed in uNK cell activation and NCR1 expression may 12 translate into alterations in artery remodeling. Measurements of arterial wall and lumen areas (µm 2 ) and 13 their ratios were performed for all the spiral arteries present in the deciduas of HFD-and LFD-fed mice 14 at Gd10.5 ( Figure 4A ). We also qualitatively assessed decidual artery smooth muscle actin (SMA) 15 expression and localization via immunofluorescence microscopy at two gestational time-points: Gd7.5 16 (prior to initiation of vascular remodeling) and Gd10.5 (when remodeling is at its peak) 39 . Vascular 17 remodeling is accompanied by the loss of SMA surrounding the vessel walls, and as such, SMA layer 18 integrity can be used as a surrogate measure of remodeling 40 . At Gd7.5 the SMA layer was intact 19 surrounding vessels in placentae of mice from both HFD-and LFD-fed ( Figure 4B ). However, by 20 Gd10.5, partial loss of SMA integrity was observed in HFD mice, while LFD mice exhibited robust 21 loss of SMA staining ( Figure 4B ). Further, at Gd10.5, HFD-fed mice had smaller vessel sizes and 22 thicker arterial walls ( Figure 4A ), and accordingly had significantly higher wall:lumen ratios at Gd10.5 23 ( Figure 4C) . Notably, the impairments in blood vessel remodeling observed at Gd10.5 in HFD mice 1 were no longer observed by Gd14.5 ( Figure 4D ). Specifically, uterine arteries from both LFD and 2 HFD-fed mice presented with dilated lumens and thin walls, indicative of proper remodeling ( Figure  3   4D ). This suggests that maternal HFD disrupts uNK-mediated vascular remodeling in early-mid 4 gestation, but that compensatory processes enable proper artery remodeling by mid-gestation. 5 6 Placental morphology at Gd14.5 is unaffected by HFD-induced obesity 7
Through regulation of angiogenesis, vascular remodeling and trophoblast invasion, uNKs play a 8 prominent role in placental development 21 . HFD-induced alterations in uNK cell composition and 9 activation, as well as impaired SA remodeling in mid-pregnancy suggest that changes in placental 10 development may also be present. To assess this, we have measured the areas (mm 2 ) of placental layers 11 from HFD-and LFD-fed mice at Gd14.5, a time-point where the murine placenta is properly developed 12 and subdivided into three definitive layers: labyrinth (L), junctional zone (Jz) and decidua (D) 41 . 13
Assessment of total placental area did not reveal any significant differences between diet groups 14 ( Figure 5A ). Moreover, the areas of individual placental layers were not altered in the context of 15 maternal HFD (Figure 5 B, C, D). Together our findings imply that HFD-related disturbances in early-16 mid gestation do not persist at late gestation, which could provide an explanation as to why the fetal 17 parameters were undisturbed following maternal exposure to HFD. 18
19

HFD potentiates altered expression of uNK-derived cytokines 20
Since HFD increased proportions of NCR1 + uNKs and induced uNK cell activity, we next set 21 out to examine if these uNK-related changes translate into altered uNK-directed cytokine expression.
Using real-time qPCR approach, we measured relative expression levels of 4 uNK-derived genes 1 known to regulate angiogenesis (VEGFA) and remodeling in uterine arteries (IFNγ, TNFα, MMP-2
2)
18,39,42,43 from flow cytometry sorted Gd10.5 total uNKs. Large variances in expression of these 3 factors were observed in uNK exposed to either diet, with expression of MMP-2 being particularly 4 heterogeneous ( Figure 6B ). Although not significant, HFD induced a modest trend in increased IFNγ 5
and TNFα, and decreased VEGFA expression ( Figure 6A , C, D) (p=0.13 for IFNγ; p=0.11 for TNFα; 6 p=0.11 for VEGFA). Our data suggest that these potential alterations in uNK cytokine expression may 7 be due to the HFD-related changes in uNK cell composition and activation. In this study, we examine the effects of maternal HFD on uNK cell biology and uterine vascular 2 transformations in early-mid pregnancy. We demonstrate that maternal HFD does not alter total uNK 3 numbers or subsets of tissue-resident or conventional cells. However, a HFD results in a selective 4 increase in the proportion of NCR1+ uNK and globally promotes uNK activation. Heightened uNK 5 activity translated into trends towards increased IFNγ and TNFα expression and decreased VEGFA 6 expression. Importantly, we show that a HFD leads to impaired spiral artery remodeling at mid-7 gestation, although this is no longer observed by late gestation. Notably, early pregnancy artery defects 8 do not impact placental morphology or fetal viability. Together, our findings show how an obesogenic 9 diet instructs changes in uNK cell function and uterine vasculature and provide novel insight into 10 underlying cellular changes that may contribute to obesity-related pregnancy disorders. 11
To our knowledge, this is the first study to examine the effects of HFD on uNK cell proportions 12 and states of activation in pregnancy. In contrast to a previous report that examined the impact of a 13 maternal western diet on mouse NK cells within draining inguinal lymph nodes of the uterus 9 , our 14 study directly examines uNK cells within the maternal-fetal interface. Since uNK within mucosal 15 tissues of the uterus are distinct from peripheral and lymphatic NKs 44-46 , the findings from our work 16 accurately describe how maternal obesity impacts immune cell function at the maternal-fetal interface. 17
Notably, we show that a HFD does not affect total leukocyte or uNK cell proportions. Due to the 18 emerging evidence supporting the presence of two distinct uNK subpopulations that differ in 19 function 21, 22 in the murine uterus, we thought it is important to decipher the effects of HFD on the 20 balance of these cells in-utero. Consistent with our findings that total uNK proportions are unchanged 21 in response to a HFD, neither tr-uNK nor c-uNK proportions were affected. This implies that a HFD 22
may not alter uNK cell infiltration or expansion into/within the uterus in early pregnancy, a finding that 23 is in contrast with other studies examining the effect of a HFD on NK infiltration into organ/tissue sites 1 like fat tissue 47, 48 . 2
Our focus on NCR1 stems from previous work reporting that Ncr1 −/− mice exhibit defects in 3 decidual angiogenesis and uterine vascular remodeling 36 . Notably, inhibition of NCR1 delays uNK cell 4 maturation and activation, reflected by smaller cell diameters and reductions in cytokine production 49 . 5
Here, we demonstrate that in mid-pregnancy a HFD leads to an increase in NCR1 + uNK cell 6
proportions. NCR1 is predominantly expressed by DBA + tr-uNKs 36 , and since we did not observe 7 changes in tr-uNK or c-uNK proportions, the increase in NCR1
-expressing uNKs may indicate that 8
DBA
-c-uNK cells exposed to a HFD are instructed to acquire or increase expression of NCR1. This 9 finding suggests that uNK exposed to a HFD undergo a state of NCR1-related compensation to 10 enhance or rescue impaired artery remodeling. Alternatively, the increase in proportions of NCR1 + 11 uNK may also translate to enhanced uNK cytotoxicity. Further work is required to more accurately 12 dissect the significance of NCR1-related changes resulting from HFD. 13
One of the additional measures of uNK activation is expression of the early activation marker 14
CD69
17 . We show that both tr-and c-uNK cells express higher levels (MFI) of CD69 in HFD-fed 15 mice. As expected, activation of uNKs was reflected by changes in their cytokine expression (increase 16 in IFNγ and TNFα, decrease in VEGFA). Although not statistically significant, likely due to an under-17 powered sample size, we believe that this finding provides important insight into uNK functional 18 changes in HFD. uNK-derived IFNγ is critical for triggering pregnancy-induced uterine vascular 19 modification, required for optimal placentation 18 . We believe that activation of uNK cells and a 20 potential increase in their IFNγ expression at Gd10.5 in HFD-fed mice is a compensatory mechanism 21 employed by these cells to assist in catching up with the vascular remodeling. This might explain why 22 HFD-induced impairment of spiral artery remodeling in our model is observed at Gd10.5 but not 23 Gd14.5. Since vascular remodeling is important for proper placentation, it was not surprising that 1 placental morphology and areas of individual placental layers in HFD-fed were not affected at Gd14.5. 2
The changes associated with uNK activation and cytokine expression in mid-pregnancy affected 3 by HFD need to be interpreted with care. While, it may be a compensatory mechanism employed by 4 these cells to rescue the defective vascular remodeling, it also may be the case that the artery 5 remodeling is impaired as a result of delayed activation and maturation of uNKs. Thus, it will be 6 important to examine the activation/maturation phenotype of uNKs throughout the gestation, starting 7 from Gd6.5 when these cells appear in the murine decidua 17 , in the context of an obesogenic 8 environment to decipher the dynamics of HFD-induced effects on uNKs. 9
Our previous study investigating the effects of maternal obesity on uNK cell function in human 10 pregnancy shows that obesity leads to fewer uNK cells within decidual tissues and, similar to our 11 findings in mice exposed to a HFD, associates with impaired vascular remodeling in early gestation 50 . 12
These similarities between obesity-and obesogenic diet-driven structural changes within uterine tissue 13 of human and mouse suggest that obesity/HFD in either species results in uNK cell alterations that 14 predispose to impairments in uterine health and function. 15
We report that fetal viability in late pregnancy (Gd14.5) is not affected by HFD. This is 16 consistent with our findings from a previous study employing the same diet conditions and strain of 17 mice, where pregnancy outcomes (fetal survival, fetal and placental weights) were not affected by a 18 HFD 33 . However, the impact of obesogenic-diets on fetal health and pregnancy outcome in rodents is 19 not consistent, where in contrast to our findings indicating that a HFD does not affect fetal survival or 20 placental structure, other studies have shown that HFD exposure in pregnancy results in both 21 reduced 51,52 and increased 53,54 fetal weight, and reduced placental labyrinth 55 and junctional zone 51 thickness, or no differences in placental weights 52,56,57 . The variation in pregnancy outcomes betweenstudies may be due to differences in animal strains, maternal age, maternal weight gain, composition of 1 the diet in terms of micro-and macronutrient content and the duration of time animals are exposed to 2
health, thus further dissecting obesity-driven immune and cellular alterations within the uterus will be 10 of substantial importance. no-sucrose control diet (CON; 10% kcal fat, 70% kcal carbohydrate (corn starch and maltodextrin), 12 20% kcal protein, 3.85 kcal/g, D12450K, Research Diets). Females were kept on the experimental diets 13 for 13 weeks prior to being paired with male studs. The appearance of a plug the next morning was 14 taken as day 0.5 of pregnancy. Because not all females became pregnant when first paired, some had 15 been on the experimental diet for 13-19 weeks at the start of pregnancy. On days 7.5, 10.5 and 14.5 of 16 pregnancy females were euthanized and their blood collected via cardiac puncture. The utero-placental 17 tissues with multiple implantation sites were collected from each mouse. 18
19
ELISA measurements of serum TNFα. Serum was purified from whole blood of females 20 sacrificed at Gd10.5 of pregnancy using serum separator tubes following standard procedures. Serum 21 levels of TNFα were determined using commercially available Mouse TNFα ELISA kit (R&D 22 systems) according to manufacturer's protocol. 23 1 Decidual leukocyte preparations. For examination of uNK cell populations, murine 2 implantation sites were separated from uterine tissues and were mechanically and enzymatically 3 processed to obtain single-cell suspensions. In brief, tissues were washed extensively in cold 4 phosphate-buffered saline (PBS; pH 7.4), and following this, tissues were minced with a razor blade 5 and subjected to a 30-minute enzymatic digestion at 37 °C in 3 mL of 1:1 DMEM/F12 media (Gibco, 6
Grand Island, NY; 200 mM L-glutamine) with 1X-collagenase/hyaluronidase (10X stock; StemCell 7
Technologies, Vancouver, Canada), 80 µg/mL DNaseI (Sigma, St. Louis, MO), 8 penicillin/streptomycin, and Anti antimycotic solution (100X dilution, Gibco). Single cell suspensions 9
were passed through a 100µm strainer and decidual leukocyte enrichment was performed by Percoll 10 (GE Healthcare) density gradient (layered 40%/80%) centrifugation. To avoid red blood cell 11 contamination, cell mixture was briefly incubated with NH 4 Cl. Decidual leukocytes were immediately 12 Gd10.5 and Gd14.5were fixed in 4% paraformaldehyde for 24-48h followed by processing into 7 paraffin blocks. Six-µm sections were stained with hematoxylin and eosin (H&E) according to standard 8 methods. For IF staining, tissues underwent antigen retrieval by heating slides in a microwave for 5 9 minutes in 30-second intervals in a sodium citrate buffer (pH 6.0). Sections were then incubated in a 10 blocking solution (5% bovine serum albumin (BSA) in Tris-buffered saline with 0.05% Tween-20 11 (TBST)) for 1 hour at room temperature. Further, samples were incubated with the following 12 antibodies overnight at 4°C: rabbit polyclonal alpha-smooth muscle actin (1:200; Abcam) and 13 biotinylated DBA (1:100; Vector Laboratories). Slides were incubated with Alexa Fluor 568/488-14 conjugated streptavidin and goat anti-rabbit secondary antibodies (Life Technologies) for 1 hour at 15 room temperature. Glass coverslips were mounted onto slides using ProLong Gold anti-fade reagent 16 containing DAPI (Life Technologies). 17 DBA + cell assessments. DBA + cell quantities in Gd7.5 and Gd10.5 implantation sites were 18 calculated based on DBA fluorescence intensity threshold. Slides were imaged using a 20x Plan-19 Apochromat/0.80 NA or a 40x EC-Plan-Neofluar/0.9 PoI objective (Carl Zeiss). Data was processed 20 and analyzed using ZenPro software (Carl Zeiss). DBA + cell diameters in Gd10.5 implantation sites 21 were measured by randomly selecting 100 DBA + uNK cells from each implantation site. Slides were 22 imaged using a 40x EC-Plan-Neofluar/0.9 PoI objective (Carl Zeiss). Using ImageJ v1.50 software 23 (NIH), the diameters of these cells were measured across their longest and shortest axes; an average 1 of both values was used for statistical analysis. All images were obtained using Axiocam 506 2 monochrome digital camera (Carl Zeiss). 3 Spiral artery remodeling assessments. Spiral artery remodeling measurements were performed 4 on H&E stained slides. For Gd10.5, (HFD: n=9 implantation sites from 8 independent pregnancies; 5 LFD: n=11 implantation sites from 9 independent pregnancies) all of the spiral arteries within the 6 decidua were measured in triplicate (three sections 48µm apart from each other). For Gd14.5, (HFD: 7 n=18 implantation sites from 7 independent pregnancies; LFD: n=17 implantation sites from 6 8 independent pregnancies) all of the spiral arteries within the decidua were measured in duplicate (two 9 sections 48µm apart from each other). Size of arterial walls and lumens was determined by measuring 10 cross-sectional areas with ImageJ v1.50 software (NIH). Wall:lumen ratios were calculated by dividing 11 the arterial wall area (µm 2 ) into the artery lumen area (µm 2 ). Slides were imaged using a 20x Plan-12 Apochromat/0.80 NA objective (Carl Zeiss). All images were obtained using Axiocam 105 color 13 digital camera (Carl Zeiss). 14 Placental morphology assessments. H&E stained slides of Gd14.5 implantation sites were 15 used for placental morphology measurements. Total area (µm 2 ) and areas of each individual 16 placental layer (µm 2 ) were measured using ImageJ v1.50 software (NIH). To normalize for 17 differences in total placental area among the measurements, individual layer area was expressed as a 18 percentage of total area at each measurement point. Slides were imaged using 10x N-19 Achroplan/0.25 Ph1 objective (Carl Zeiss). All images were obtained using Axiocam 105 color 20 digital camera (Carl Zeiss). 21 RNA preparation, cDNA synthesis, and qPCR. Prior to RNA extraction, CD45+CD3-1 CD122+ uNK cells from Gd10.5 implantation sites were isolated by FACS using a FACSAria flow 2 cytometry (BD Biosciences). Total RNA was prepared from isolated uNKs using TRIzol LS reagent 3 (Ambion) following by RNeasy MinElute Cleanup (Qiagen) and DNase treatment (Ambion) 4 according to manufacturers' protocols. RNA purity was confirmed using a NanoDrop 5
Spectrophotometer (Thermo Fisher Scientific) and Agilent 2100 Bioanalyzer (Agilent). Only RNA 6 samples having an RNA integrity number (RIN) greater than 8.0 were used. RNA was reverse-7 transcribed using a first-strand cDNA synthesis kit (Quanta Biosciences) and subjected to qPCR 8 (∆∆CT) analysis, using PerfeCTa SYBR Green FastMix Low ROX (Quanta Biosciences) on an ABI 9
ViiA 7 Real-Time PCR system (Thermo Fisher Scientific). Forward and reverse primer sets used as 10 
